3h
Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board
Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the ...
Tectonic Therapeutic named François Nader as chair and independent director of its board, effective April 1.
Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the ...
Some seven months after sounding the strategic search alarm, Avrobio will merge with Tectonic Therapeutic, with the latter’s GPCR-targeted meds now the combined company's clinical focus. The biotechs’ ...
New research reveals the source of this carbon – and the driving forces behind it – are far more complex than previously ...
Scientists have produced the first global map and analysis of small mare ridges (SMRs) on the moon, a characteristic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results